Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 121

    1.

    Tadalafil in primary pulmonary arterial hypertension.

    Palmieri EA, Affuso F, Fazio S, Lembo D.

    Ann Intern Med. 2004 Nov 2;141(9):743-4. No abstract available. PMID: 15520445 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Sildenafil citrate therapy for pulmonary arterial hypertension.

    Izbicki G, Rosengarten D, Picard E.

    N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3. No abstract available. PMID: 16528809 [PubMed - indexed for MEDLINE]Related articles

    3.

    Sildenafil in primary pulmonary hypertension.

    Prasad S, Wilkinson J, Gatzoulis MA.

    N Engl J Med. 2000 Nov 2;343(18):1342. No abstract available. PMID: 11183578 [PubMed - indexed for MEDLINE]Related articles

    4.

    Sildenafil citrate therapy for pulmonary arterial hypertension.

    Kuschner WG.

    N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3. No abstract available. PMID: 16528810 [PubMed - indexed for MEDLINE]Related articles

    5.

    Sildenafil in pulmonary hypertension.

    Nanivadekar A.

    Indian Heart J. 2003 May-Jun;55(3):285; author reply 285. No abstract available. PMID: 14560947 [PubMed - indexed for MEDLINE]Related articles

    6.

    Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.

    Raja SG, Danton MD, MacArthur KJ, Pollock JC.

    J Cardiothorac Vasc Anesth. 2006 Oct;20(5):722-35. Epub 2006 Apr 5. Review. No abstract available. PMID: 17023298 [PubMed - indexed for MEDLINE]Related articles

    7.

    Sildenafil citrate therapy for pulmonary arterial hypertension.

    Hoeper MM, Welte T.

    N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3. No abstract available. PMID: 16525151 [PubMed - indexed for MEDLINE]Related articles

    8.

    Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon.

    Rosenkranz S, Diet F, Karasch T, Weihrauch J, Wassermann K, Erdmann E.

    Ann Intern Med. 2003 Nov 18;139(10):871-3. No abstract available. PMID: 14623635 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.

    Hoeper MM.

    Eur Respir J. 2007 Mar;29(3):432-4. No abstract available. PMID: 17329488 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Sildenafil for enhanced performance at high altitude?

    Rubin LJ, Naeije R.

    Ann Intern Med. 2004 Aug 3;141(3):233-5. No abstract available. PMID: 15289224 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Summaries for patients. Sildenafil increases exercise capacity in low-oxygen settings.

    [No authors listed]

    Ann Intern Med. 2004 Aug 3;141(3):I12. No abstract available. PMID: 15289233 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.

    Chaudhari M, Vogel M, Wright C, Smith J, Haworth SG.

    Arch Dis Child Fetal Neonatal Ed. 2005 Nov;90(6):F527-8.PMID: 16244212 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors]

    Ghofrani HA, Grimminger F.

    Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S311-4. Review. German. PMID: 17139594 [PubMed - indexed for MEDLINE]Related articles

    14.

    Summary for patients. Sildenafil (Viagra) may help improve control of pulmonary hypertension.

    [No authors listed]

    Ann Intern Med. 2002 Apr 2;136(7):I35. No abstract available. PMID: 11926808 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension.

    Hemnes AR, Champion HC.

    Expert Rev Cardiovasc Ther. 2006 May;4(3):293-300. Review.PMID: 16716091 [PubMed - indexed for MEDLINE]Related articles

    16.

    Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.

    Lewis GD, Semigran MJ.

    Curr Heart Fail Rep. 2004 Dec;1(4):183-9. Review.PMID: 16036043 [PubMed - indexed for MEDLINE]Related articles

    17.

    Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.

    Tsai BM, Turrentine MW, Sheridan BC, Wang M, Fiore AC, Brown JW, Meldrum DR.

    Ann Thorac Surg. 2006 Jan;81(1):272-8.PMID: 16368379 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sildenafil citrate for the treatment of pulmonary hypertension.

    Hrometz SL, Shields KM.

    Drugs Today (Barc). 2006 Dec;42(12):771-84. Review.PMID: 17285150 [PubMed - indexed for MEDLINE]Related articles

    19.

    [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma]

    Humbert M.

    Rev Med Interne. 2007 Dec;28 Suppl 4:S273-6. Epub 2007 Oct 8. French. No abstract available. PMID: 17961866 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sildenafil citrate therapy for pulmonary arterial hypertension.

    Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.

    N Engl J Med. 2005 Nov 17;353(20):2148-57. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2400-1. PMID: 16291984 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data